Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ray Borrow

Showing results (171-180 of 403) with videos related to

Pageof 41
Sort By:
Vaccine|August 14, 2016
Distribution of Bexsero® Antigen Sequence Types (BASTs) in invasive meningococcal disease isolates: Implications for immunisationCarina Brehony, Charlene M C Rodrigues, Ray Borrow, et al.
Life (Basel, Switzerland)|April 3, 2021
Self-Reported Real-World Safety and Reactogenicity of COVID-19 Vaccines: A Vaccine Recipient SurveyAlexander G Mathioudakis, Murad Ghrew, Andrew Ustianowski, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|May 12, 2026
Lower incidence and higher case fatality rates associated with invasive meningococcal disease during COVID-19 pandemic restrictions (March 2020 to July 2021) in EnglandEmma J Heymer, Helen Campbell, Stephen A Clark, et al.
Clinical and Vaccine Immunology : CVI|December 19, 2008
Immunogenicity of a reduced schedule of meningococcal group C conjugate vaccine given concomitantly with the Prevenar and Pediacel vaccines in healthy infants in the United KingdomJo Southern, Ray Borrow, Nick Andrews, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 11, 2015
Neisseria meningitidis Group A IgG1 and IgG2 Subclass Immune Response in African Children Aged 12-23 Months Following Meningococcal VaccinationDaniel Holme, Helen Findlow, Samba O Sow, et al.
Human Vaccines & Immunotherapeutics|September 22, 2017
Neisseria meningitidis Serogroup X ST-5799 (ST-22 complex) in Turkey: A unique pediatric caseGönül Tanır, Yasemin Ozsurekci, Jay Lucidarme, et al.
The Journal of Infectious Diseases|November 2, 2022
Genome-Wide Association Studies Identify an Association of Transferrin Binding Protein B Variation and Invasive Serogroup Y Meningococcal Disease in Older AdultsLaura Maynard-Smith, Jeremy P Derrick, Ray Borrow, et al.
Vaccine|April 28, 2018
Epidemiology, clinical presentation, risk factors, intensive care admission and outcomes of invasive meningococcal disease in England, 2010-2015Sydel R Parikh, Helen Campbell, Stephen J Gray, et al.
Emerging Infectious Diseases|March 20, 2018
Genomic Surveillance of 4CMenB Vaccine Antigenic Variants among Disease-Causing Neisseria meningitidis Isolates, United Kingdom, 2010-2016Charlene M C Rodrigues, Jay Lucidarme, Ray Borrow, et al.
Clinical and Diagnostic Laboratory Immunology|May 10, 2005
Analysis of human serum immunoglobulin G against O-acetyl-positive and O-acetyl-negative serogroup W135 meningococcal capsular polysaccharidePeter C Giardina, Emma Longworth, Renee E Evans-Johnson, et al.
Pageof 41

Showing results (171-180 of 403) with videos related to

Sort By:
Pageof 41
Vaccine|August 14, 2016
Distribution of Bexsero® Antigen Sequence Types (BASTs) in invasive meningococcal disease isolates: Implications for immunisationCarina Brehony, Charlene M C Rodrigues, Ray Borrow, et al.
Life (Basel, Switzerland)|April 3, 2021
Self-Reported Real-World Safety and Reactogenicity of COVID-19 Vaccines: A Vaccine Recipient SurveyAlexander G Mathioudakis, Murad Ghrew, Andrew Ustianowski, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|May 12, 2026
Lower incidence and higher case fatality rates associated with invasive meningococcal disease during COVID-19 pandemic restrictions (March 2020 to July 2021) in EnglandEmma J Heymer, Helen Campbell, Stephen A Clark, et al.
Clinical and Vaccine Immunology : CVI|December 19, 2008
Immunogenicity of a reduced schedule of meningococcal group C conjugate vaccine given concomitantly with the Prevenar and Pediacel vaccines in healthy infants in the United KingdomJo Southern, Ray Borrow, Nick Andrews, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 11, 2015
Neisseria meningitidis Group A IgG1 and IgG2 Subclass Immune Response in African Children Aged 12-23 Months Following Meningococcal VaccinationDaniel Holme, Helen Findlow, Samba O Sow, et al.
Human Vaccines & Immunotherapeutics|September 22, 2017
Neisseria meningitidis Serogroup X ST-5799 (ST-22 complex) in Turkey: A unique pediatric caseGönül Tanır, Yasemin Ozsurekci, Jay Lucidarme, et al.
The Journal of Infectious Diseases|November 2, 2022
Genome-Wide Association Studies Identify an Association of Transferrin Binding Protein B Variation and Invasive Serogroup Y Meningococcal Disease in Older AdultsLaura Maynard-Smith, Jeremy P Derrick, Ray Borrow, et al.
Vaccine|April 28, 2018
Epidemiology, clinical presentation, risk factors, intensive care admission and outcomes of invasive meningococcal disease in England, 2010-2015Sydel R Parikh, Helen Campbell, Stephen J Gray, et al.
Emerging Infectious Diseases|March 20, 2018
Genomic Surveillance of 4CMenB Vaccine Antigenic Variants among Disease-Causing Neisseria meningitidis Isolates, United Kingdom, 2010-2016Charlene M C Rodrigues, Jay Lucidarme, Ray Borrow, et al.
Clinical and Diagnostic Laboratory Immunology|May 10, 2005
Analysis of human serum immunoglobulin G against O-acetyl-positive and O-acetyl-negative serogroup W135 meningococcal capsular polysaccharidePeter C Giardina, Emma Longworth, Renee E Evans-Johnson, et al.
Pageof 41